Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Patnaik

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Europe-Asia Studies|January 1, 1995
Agriculture and rural out-migration in Central Asia, 1960-91A Patnaik
Journal of the American Veterinary Medical Association|April 15, 1978
Primary urethral tumors in dogsG Tarvin, A Patnaik, R Greene
Anti-Cancer Drugs|January 16, 1999
Palliative therapy in advanced ovarian cancer: balancing patient expectations, quality of life and costA Patnaik, C Doyle, A M Oza
Proceedings of the National Academy of Sciences of the United States of America|November 23, 2000
Ubiquitin is part of the retrovirus budding machineryA Patnaik, V Chau, J W Wills
Indian Journal of Psychiatry|May 18, 2011
A study on the venues of suicideR Ponnudurai, K A Patnaik, R Sathianathan, et al.
Cancer Chemotherapy and Pharmacology|July 9, 2010
Mechanism-based pharmacokinetic/pharmacodynamic model for troxacitabine-induced neutropenia in cancer patientsChee M Ng, A Patnaik, M Beeram, et al.
Journal of Diabetes and Its Complications|January 5, 2000
Plasma homocysteine concentrations in type II diabetic patients in India: relationship to body weightS Das, T Reynolds, A Patnaik, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2000
Phase I/II trial of cyclophosphamide, mitoxantrone, and escalated doses of carboplatin supported by peripheral-blood stem cells in women with metastatic breast cancerA Patnaik, J MacKinnon, P Goss, et al.
Journal of Biological Response Modifiers|August 1, 1985
Levamisole as adjuvant to chemotherapy for canine lymphosarcomaE G MacEwen, A A Hayes, S Mooney, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 19, 2003
A phase I study of bizelesin, a highly potent and selective DNA-interactive agent, in patients with advanced solid malignanciesG H Schwartz, A Patnaik, L A Hammond, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Europe-Asia Studies|January 1, 1995
Agriculture and rural out-migration in Central Asia, 1960-91A Patnaik
Journal of the American Veterinary Medical Association|April 15, 1978
Primary urethral tumors in dogsG Tarvin, A Patnaik, R Greene
Anti-Cancer Drugs|January 16, 1999
Palliative therapy in advanced ovarian cancer: balancing patient expectations, quality of life and costA Patnaik, C Doyle, A M Oza
Proceedings of the National Academy of Sciences of the United States of America|November 23, 2000
Ubiquitin is part of the retrovirus budding machineryA Patnaik, V Chau, J W Wills
Indian Journal of Psychiatry|May 18, 2011
A study on the venues of suicideR Ponnudurai, K A Patnaik, R Sathianathan, et al.
Cancer Chemotherapy and Pharmacology|July 9, 2010
Mechanism-based pharmacokinetic/pharmacodynamic model for troxacitabine-induced neutropenia in cancer patientsChee M Ng, A Patnaik, M Beeram, et al.
Journal of Diabetes and Its Complications|January 5, 2000
Plasma homocysteine concentrations in type II diabetic patients in India: relationship to body weightS Das, T Reynolds, A Patnaik, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2000
Phase I/II trial of cyclophosphamide, mitoxantrone, and escalated doses of carboplatin supported by peripheral-blood stem cells in women with metastatic breast cancerA Patnaik, J MacKinnon, P Goss, et al.
Journal of Biological Response Modifiers|August 1, 1985
Levamisole as adjuvant to chemotherapy for canine lymphosarcomaE G MacEwen, A A Hayes, S Mooney, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 19, 2003
A phase I study of bizelesin, a highly potent and selective DNA-interactive agent, in patients with advanced solid malignanciesG H Schwartz, A Patnaik, L A Hammond, et al.
Pageof 4